1. Home
  2. DNOW vs LQDA Comparison

DNOW vs LQDA Comparison

Compare DNOW & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNOW
  • LQDA
  • Stock Information
  • Founded
  • DNOW 1862
  • LQDA 2004
  • Country
  • DNOW United States
  • LQDA United States
  • Employees
  • DNOW N/A
  • LQDA N/A
  • Industry
  • DNOW Metal Fabrications
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • DNOW Industrials
  • LQDA Health Care
  • Exchange
  • DNOW Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • DNOW 2.3B
  • LQDA 2.5B
  • IPO Year
  • DNOW N/A
  • LQDA 2018
  • Fundamental
  • Price
  • DNOW $13.95
  • LQDA $32.15
  • Analyst Decision
  • DNOW Strong Buy
  • LQDA Strong Buy
  • Analyst Count
  • DNOW 3
  • LQDA 10
  • Target Price
  • DNOW $17.33
  • LQDA $37.40
  • AVG Volume (30 Days)
  • DNOW 3.2M
  • LQDA 2.7M
  • Earning Date
  • DNOW 11-05-2025
  • LQDA 11-03-2025
  • Dividend Yield
  • DNOW N/A
  • LQDA N/A
  • EPS Growth
  • DNOW N/A
  • LQDA N/A
  • EPS
  • DNOW 0.87
  • LQDA N/A
  • Revenue
  • DNOW $2,432,000,000.00
  • LQDA $69,216,000.00
  • Revenue This Year
  • DNOW $5.86
  • LQDA $424.31
  • Revenue Next Year
  • DNOW $3.22
  • LQDA $359.32
  • P/E Ratio
  • DNOW $16.04
  • LQDA N/A
  • Revenue Growth
  • DNOW 3.18
  • LQDA 343.41
  • 52 Week Low
  • DNOW $12.01
  • LQDA $10.37
  • 52 Week High
  • DNOW $18.45
  • LQDA $32.41
  • Technical
  • Relative Strength Index (RSI)
  • DNOW 53.97
  • LQDA 70.67
  • Support Level
  • DNOW $12.01
  • LQDA $27.76
  • Resistance Level
  • DNOW $13.41
  • LQDA $30.50
  • Average True Range (ATR)
  • DNOW 0.66
  • LQDA 1.85
  • MACD
  • DNOW 0.13
  • LQDA 0.36
  • Stochastic Oscillator
  • DNOW 77.31
  • LQDA 98.23

About DNOW NOW Inc.

Dnow Inc is a company engaged in world-wide supplying of energy and industrial products and packaged, engineered process and production equipment with a legacy of over one sixty years. It offers a broad set of supply chain solutions combined with a suite of digital solutions branded as DigitalNOW that provide customers world-class technology for digital commerce, data and information management. Its locations provide products and solutions to exploration and production companies, midstream transmission and storage companies, refineries, chemical companies, utilities, mining, municipal water, manufacturers, engineering and construction companies. The Company has three reportable segments being United States, Canada and International.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: